Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
About
 Advertising
 Home
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Facilities
 

EquipNet Auction: Sell Your Used Lab and Analytical Equipment Now!

North American Biotech Roadshow Featuring Grad Students, Post-Docs & Start-Up “Do’s & Don’ts”

Check Out Our Newest Cartoon: Your COVID-19 Wheel of Fortune


Texas Life Science Industry Directory

World Hepatitis Day

Banner Advertising

Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and delayed by COVID-19, to be launched in 2022 replacing TexasLifeScience.com. Regrettably, we are working with reduced staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved directory upon the launch of the new site. We apologize for the inconvenience.

Trans Ova Genetics


Trans Ova Genetics
1233 State Hwy 7
Centerville, TX 75883
Trans Ova Genetics
 
Phone: (866) 924-4586
Year Established:  1980
Ticker: XON
Exchange: NYSE
Main Contact: Mark Allan, Director of Marketing and Genomics
 
Company Description

Trans Ova Genetics provides industry-leading reproductive technologies and expertise to cattle breeders through a unique professional services team that works closely with clients to understand their breeding goals, and ultimately help clients advance and extend superior genetics. Trans Ova Genetics understands the process that will help multiply a herd's genetic success. Internationally recognized as a source of superior animal husbandry and reproductive expertise, Trans Ova Genetics offers an integrated system of regional centers, satellite stations and on-farm application of reproductive technologies.

On August 11, 2014, Intrexon announced it had completed its acquisition of acquire Trans Ova Genetics. Trans Ova stockholders received $60 million in cash, $30 million in Intrexon common stock, and $20 million in deferred payments to be paid in three equal installments.



Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2022 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

TexasLifeScience.com is owned and published by Info.Resource, Inc.